The distinct metabolic profile of renal cancer is intimately associated with its sensitivity to ferroptosis, with multiple molecular mechanisms implicated in the regulation of ferroptosis in renal cancer, including PDIA4, GPX4, KLF2, ACSL3, and AIM2. This evidence concerns the gene ACSL3 and renal carcinoma.